Ketohexokinase (KHK) iRNA compositions and methods of use thereof
US12404508B2 · kind B2 · utility
0Cited by
5References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2023 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Oct 16, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/53
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the ketohexokinase (KHK) gene. The invention also relates to methods of using such RNAi agents to inhibit expression of a KHK gene and to methods of treating or preventing a KHK-associated disorder in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.